Smith Christopher M
- SEC CIK
- 0001436707
No open-market purchases or sales filed in the past year.
Current role at each company
- PACB Pacific Biosciences of California, Inc.Directoras of Jun 4, 2026
- NEO Neogenomics IncChief Executive Officeras of Feb 25, 2025
- QDEL QuidelOrtho CorpDirectoras of Jun 8, 2023
- AKUS Akouos, Inc.Directoras of Jun 27, 2022
- OCDX Ortho Clinical Diagnostics Holdings plcChairman and CEOas of Jun 1, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Smith Christopher M as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
OCDX Ortho Clinical Diagnostics Holdings plc
Chairman and CEO2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2022 (view filing) | Jan 3 | 2 days | Smith Christopher MChairman and CEO | SSaleOrdinary Shares, $0.00001 par value | −100.0K | $21.10 | −$2.11M | −21.4%367.4K after | |
| Aug 4, 2021 (view filing) | Aug 2-4 | 2 days | Smith Christopher MChairman and CEO | SSaleOrdinary Shares, $0.00001 par value | −270.0K | $21.82 | −$5.89M | −42.4%367.4K after | 3 lots |